MarketPulse

shareholder dilution

14 articles
The Motley FoolThe Motley Fool··Rich Smith

Unusual Machines Stock Plunges 15.6% on $150M Below-Market Share Offering

Unusual Machines stock fell 15.6% after announcing a $150M share offering at $17, below the $18.60 closing price, diluting shareholders 22.6% despite strong cash reserves.
UMACstock offeringshareholder dilution
The Motley FoolThe Motley Fool··Johnny Rice

New Fortress Energy Shareholders Face 65% Dilution in Debt Restructuring Deal

NFE stock plummets 20.3% after announcing debt restructuring. Shareholders diluted to 35% ownership; creditors gain 65% stake plus $2.5B in preferred shares.
NFEshareholder dilutionliquefied natural gas
The Motley FoolThe Motley Fool··Johnny Rice

NFE Stock Surges Then Tumbles as Debt Deal Brings Heavy Shareholder Dilution

New Fortress Energy slashed debt 91% in restructuring, but shareholders face 65% ownership dilution and creditor takeover of Brazilian operations.
NFEshareholder dilutionliquefied natural gas
BenzingaBenzinga··Stjepan Kalinic

Tech Giants Slash Costs Amid Structural Challenges Masked by AI Narrative

Major tech companies cite AI automation for massive layoffs, but underlying issue stems from pandemic-era overhiring and unsustainable equity-heavy compensation models.
XYZAMZNHUBSshareholder dilutionfree cash flow
The Motley FoolThe Motley Fool··James Brumley

CRISPR Stock Plunges 12% on $350M Convertible Debt Offering

CRISPR Therapeutics stock fell 12% after announcing a $350M convertible debt offering. Analysts remain bullish, suggesting the decline may present a buying opportunity.
CRSPstock declineshareholder dilution
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Altria's Cash Machine Outpaces Cannabis Volatility as Tilray Struggles

Altria's proven profitability and 6.1% dividend outshine Tilray's persistent losses and shareholder dilution in cannabis sector comparison.
TLRYMOshareholder dilutiondividend yield
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Canopy Growth's 99% Collapse Raises Hard Questions for Remaining Shareholders

Cannabis leader $CGC has crashed 99% from $568 peak to ~$1, facing profitability challenges and dilutive acquisition amid intense competition.
CGCstock declineacquisition
The Motley FoolThe Motley Fool··Rich Smith

Red Cat Holdings Shares Decline on Secondary Offering Concerns

Red Cat Holdings shares fell 11.2% amid concerns it may pursue secondary offerings like competitor Kratos Defense to fund its $70 million annual cash burn.
RCATKTOSstock offeringshareholder dilution
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Canopy Growth's Dramatic Collapse: Evaluating Investor Options in Distressed Cannabis Stock

Canopy Growth stock collapsed 99.8% to penny-stock status amid operational losses and sector cooling. Investors face potential tax-loss harvesting strategies rather than speculative recovery bets.
CGCshareholder dilutionmarijuana stocks
The Motley FoolThe Motley Fool··Courtney Carlsen

Plug Power Pursues Turnaround as Losses Mount Amid Clean Energy Pivot

Plug Power launches restructuring initiative to stem mounting losses and pivot toward higher-margin hydrogen production, supported by strengthening green energy policies.
WMTAMZNPLUGshareholder dilutioncost reduction
The Motley FoolThe Motley Fool··Manali Pradhan, Cfa

D-Wave Quantum Stock Plunges 60% Amid Valuation Concerns Despite Revenue Growth

D-Wave Quantum stock plunged 60% from October peak despite 235% revenue growth, as investors question its 299x sales valuation and integration risks from recent acquisition.
QBTSshareholder dilutionstock valuation
The Motley FoolThe Motley Fool··Brett Schafer

Valuation Challenges Cloud Rocket Lab's Long-Term Growth Prospects

Rocket Lab's 900% revenue growth is impressive, but its $40B valuation may already price in future gains amid thin margins and shareholder dilution concerns.
RKLBshareholder dilutionElectron rocket
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Psyence BioMed Executes Put Option, Issues $5M in Shares to PsyLabs

Psyence BioMed issues $5M in shares to PsyLabs via put option exercise, giving PsyLabs ~50% ownership and strengthening supply chain for psychedelic pharmaceuticals.
PBMPBMWWsupply chainshareholder dilution
The Motley FoolThe Motley Fool··Johnny Rice

Quantum Computing Inc. Faces Scrutiny Over Valuation Gap and Revenue Concerns

Quantum Computing Inc. faces scrutiny over its $1.9B valuation versus just $546K revenue, with analysts citing cash burn concerns and questions about management credibility.
GOOGGOOGLIBMQUBTshareholder dilutionstock valuation